These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3298472)

  • 1. Assessment of the immune deficit in leprosy patients and the effect of recombinant IL-2 in vitro.
    Locniskar M; McEniry DW; Mudd DW; Rose P; Lucas DC; Larrick J; McAdam KP
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):249-60. PubMed ID: 3298472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin.
    Barnass S; Mace J; Steele J; Torres P; Gervasoni B; Ravioli R; Terencio J; Rook GA; Waters MF
    Clin Exp Immunol; 1986 Apr; 64(1):41-9. PubMed ID: 2426020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
    Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological profile of treated lepromatous leprosy patients.
    Joshi B; Girdhar BK; Mohanty KK; Beuria MK; Girdhar A; Sengupta U
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):195-203. PubMed ID: 11875763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
    Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
    Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
    Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
    Nath I; Singh R
    Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
    Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.
    Menzel S; Harboe M; Bergsvik H; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):617-25. PubMed ID: 3323365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide does not modify the ability of cells in leprosy patients to incorporate [3H]-thymidine when incubated with M. leprae antigens.
    Tadesse A; Taye E; Sandoval F; Shannon EJ
    Lepr Rev; 2003 Sep; 74(3):206-14. PubMed ID: 14577465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease.
    de Jong R; Janson AA; Faber WR; Naafs B; Ottenhoff TH
    J Immunol; 1997 Jul; 159(2):786-93. PubMed ID: 9218596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of cell-mediated immune contrasuppression in lepromatous leprosy: modulation of a putative T contrasuppressor cell-subset.
    González-Amaro R; Salazar-González JF; Baranda L; Abud-Mendoza C; Moncada B; García R; Alcocer-Varela J
    Clin Exp Immunol; 1988 Mar; 71(3):399-404. PubMed ID: 3133142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation.
    Bjune G
    Int J Lepr Other Mycobact Dis; 1978; 46(3-4):386-93. PubMed ID: 83309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients.
    Bach MA; Wallach D; Flageul B; Cottenot F
    Clin Exp Immunol; 1983 Apr; 52(1):107-14. PubMed ID: 6345031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type.
    Prasad HK; Mishra RS; Nath I
    J Exp Med; 1987 Jan; 165(1):239-44. PubMed ID: 3540178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.